Evidence map›Paper›PMID 20455057›Full record

ArticleMedizinische Klinik (Munich, Germany : 1983)2010

[Serious course of a miliary tuberculosis in a 34-year-old patient with ulcerative colitis and HIV infection under concomitant therapy with infliximab].

Jonas Zeitz, Milo Huber, Gerhard Rogler

Open access · greenAbstract readCase ReportsEnglish Abstract
PubMed Publisher
In one paragraph

Article in Medizinische Klinik (Munich, Germany : 1983), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Obesity and pancreatitis.Current opinion in gastroenterology · 2017
    Review
  2. Article
  3. Role of pancreatic fat in the outcomes of pancreatitis.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jonas ZeitzKlinik für Gastroenterologie und Hepatologie, Universitäts Spital Zürich, Zürich, Schweiz.
Milo Huber
Gerhard Rogler
See-Spital · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 34-year-old HIV-positive patient with ulcerative colitis was transferred to the authors' hospital because of progressive worsening of his general condition with intermittent fever, increasing lymphopenia, anemia, thrombopenia and neutropenia under anti-tumor necrosis factor-(TNF-)alpha therapy with infliximab. In spite of negative screening tests before initiation of infliximab therapy and intermittent tests during treatment, miliary tuberculosis was finally diagnosed and a tuberculostatic therapy was started. The patient's clinical condition worsened due to the development of a serious exudative necrotizing pancreatitis which was likely to be caused by the tuberculostatic treatment. Due to severe pulmonary infiltrates and pleural effusions with respiratory failure the patient finally passed away.

Indexed as

AdultAIDS-Related Opportunistic InfectionsAntibodies, MonoclonalAnti-Inflammatory AgentsAntitubercular AgentsColitis, UlcerativeComorbidityDiagnosis, DifferentialDisease ProgressionDrug Therapy, CombinationFatal OutcomeHumansInfliximabMalePancreasPancreatitis, Acute NecrotizingAntibodies, MonoclonalAnti-Inflammatory AgentsAntitubercular AgentsInfliximab

Identifiers

PMID20455057
OpenAlexW1825112287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.